Capitalize on Enzyme Evolution through HTP Screening, Advanced Engineering & Deploy Maturing Biocatalysis Techniques in Small Molecules & Complex Modalities
Unlock the Future of Biocatalysis at the 4th Applied Biocatalysis & Enzyme Engineering Summit
Transform Drug Discovery & Development through Enzymes & Green Biocatalysis
Welcome to a pivotal moment in the Golden Age of Biocatalysis, where industry leaders like Eli Lilly and Pfizer are transforming small molecule operations and biopharma is pushing the boundaries of biologics development. This year, we’re witnessing ground breaking advancements as biocatalysis becomes central to biologics and therapeutic innovation.
In collaboration with Merck, Novo Nordisk and Pfizer, we’re excited to bring you the 4th Applied Biocatalysis & Enzyme Engineering Summit - now with a sharper focus on enzyme engineering and expanded coverage of biocatalysis-derived oligonucleotides, peptides and other large biologics. Plus, dive into brand-new biopharma case studies designed to boost enzyme efficiency and therapeutic yields.
Why Attend?
- Revolutionize Biologics Development: Discover cutting-edge oligonucleotide production case studies that are setting new standards in biologics
- Streamline Enzyme Discovery: Learn how to prioritize and engineer enzymes from early-stage proof of concept to accelerate your pipeline
- Fast-Track Decision Making: Master modern prediction methods and sophisticated high-throughput techniques to refine enzyme selection
- Optimize Small Molecule Biocatalysis: Gain insights from pharma-led projects focused on enhancing activity, yields and green chemistry
Join over 80 enzyme discovery, engineering, biocatalysis, and process chemistry professionals from both industry and academia. Let’s innovate and elevate drug development pipelines together through the power of green biocatalysis.
World Class Speaker Faculty Includes:
Previously Attending Companies Include:
Past Attendees of Our Applied Biocatalysis Said:
“The calibre of presentations was great and the impactful research updates they were able to share. The networking was excellent as well!”
Senior Director
Chemical Biotechnologies, Merck, Previous Attendee
“The content of the presentations was well-suited for the group, some really great presentations. Also appreciated the broad engagement from the attendees.”
Principal Scientist, AbbVie, Previous Attendee
“I really enjoyed the smaller group setting making the Summit a great meeting for connecting and information exchanging.”
Director & Head of Small Molecule Chemistry Development, Biogen,
Previous Attendee
“I enjoyed being able to connect with people that were in the process of developing Biocatalysis techniques in their labs. This was really helpful for me as I am early in the process of implementation.”
Principal Scientist, Novo Nordisk, Previous Attendee
Other Events in the Series:
